Navigation Links
VersaStep™ Plus Instrument

ProductsVersaStep™ Plus Instrument
Company Autosuture
Item VersaStep™ Plus Instrument
Features 
  • For applications in laparoscopic procedures
  • 100 mm working length
  • Unique non-bladed access device utilizing radial dilation
  • Used to establish entry into the abdominal thoracic cavities
  • 3 units per box
  • 6 units per box (VS101000 only)
  • 10 units per box (S100000 only)
  • Description VersaStep Plus Instrument for applications in laparoscopic procedures.

    The VERSASTEP™ Plus instrument with 100 mm working length is a unique non-bladed access device utilizing radial dilation. It is used to establish entry into the abdominal thoracic cavities.
    Info Autosuture
    Customer Service: (800) 722-8772
    Web site: http://www.autosuture.com

    Related medicine products :

    1. VersaStep™ Plus Long Instrument with 150 mm Working Length
    2. VersaStep™ Plus Short Instrument with 70 mm Working Length
    3. VersaStep™ Reposable Powershield™ (Reusable Radiolucent Cannulae - Short Length)
    4. VersaStep™ Reposable Short Single-Use Instruments
    5. VersaStep™ SHORT Reposable (Reusable Components - Short Length)
    6. VersaStep™ Reposable (Reusable Components - Standard Length)
    7. Microsurgical Instrument Tray
    8. Instrument Tray
    9. Mayo Instrument Stand
    10. Mobile Instrument Stand
    11. Ultramatic RX Master PHOROPTOR Refracting Instrument - Minus Cylinder Black
    ... an innovative handheld device for ... non-invasively, comfortably, and accurately.,It is, ... than an automatic blood pressure ... charge, Vasotrax will take approximately ...
    ... Insulin-like growth factor II (IGF-II) is a 7.5 ... liver and is postulated to have mitogenic and ... of IGF-II are mediated by binding to target ... the Type II IGF receptor, a monomeric protein ...
    ... Pregnancy-associated plasma protein A (PAPP-A) is ... is produced in high concentrations by ... into the maternal circulation in increasing ... PAPP-A is not specific to pregnancy ...
    ... Pregnancy-associated plasma protein A (PAPP-A) ... PAPP-A is produced in high concentrations ... released into the maternal circulation in ... [1]. PAPP-A is not specific to ...
    Medicine Products:
    (Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
    (Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
    (Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
    (Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
    (Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
    Breaking Medicine News(10 mins):
    (Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
    (Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
    (Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
    Breaking Medicine Technology: